Cite
HARVARD Citation
Ramesh, D. et al. (2022). First‐in‐class pyrido[2, 3‐d]pyrimidine‐2, 4(1H, 3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights. Archiv der Pharmazie. 355 (4), p. n/a. [Online].